Kodiak Sciences, Inc. (KOD)
88.12
+7.03
(+8.67%)
USD |
NASDAQ |
Oct 15, 16:00
88.19
+0.07
(+0.08%)
After-Hours: 20:00
Kodiak Sciences Cash from Operations (TTM) : -158.50M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -158.50M |
| March 31, 2026 | -146.94M |
| December 31, 2025 | -136.01M |
| September 30, 2025 | -126.70M |
| June 30, 2025 | -114.98M |
| March 31, 2025 | -106.80M |
| December 31, 2024 | -117.32M |
| September 30, 2024 | -119.49M |
| June 30, 2024 | -131.10M |
| March 31, 2024 | -146.56M |
| December 31, 2023 | -154.18M |
| September 30, 2023 | -177.02M |
| June 30, 2023 | -197.34M |
| March 31, 2023 | -210.52M |
| Date | Value |
|---|---|
| December 31, 2022 | -206.46M |
| September 30, 2022 | -210.42M |
| June 30, 2022 | -209.28M |
| March 31, 2022 | -190.80M |
| December 31, 2021 | -182.27M |
| September 30, 2021 | -150.25M |
| June 30, 2021 | -122.88M |
| March 31, 2021 | -100.12M |
| December 31, 2020 | -83.43M |
| September 30, 2020 | -67.70M |
| June 30, 2020 | -50.83M |
| March 31, 2020 | -49.87M |
| December 31, 2019 | -39.15M |
| September 30, 2019 | -36.19M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 4.681B |
| AbbVie, Inc. | 19.51B |
| Mirum Pharmaceuticals, Inc. | -227.27M |
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |